Chronic Viral Hepatitis: Current Management and Future Directions von Do, Albert, Reau, Nancy S.

Volltext

The Importance of Making an Accurate Diagnosis for Hepatic Encephalopathy von Reau, Nancy S

Volltext

Hepatocellular Carcinoma and Hepatitis Delta Virus von Reau, Nancy S

Volltext

American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease von Fix, Oren K., Blumberg, Emily A., Chang, Kyong‐Mi, Chu, Jaime, Chung, Raymond T., Goacher, Elizabeth K., Hameed, Bilal, Kaul, Daniel R., Kulik, Laura M., Kwok, Ryan M., McGuire, Brendan M., Mulligan, David C., Price, Jennifer C., Reau, Nancy S., Reddy, K. Rajender, Reynolds, Andrew, Rosen, Hugo R., Russo, Mark W., Schilsky, Michael L., Verna, Elizabeth C., Ward, John W., Fontana, Robert J.

Volltext

Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis von Thomaides-Brears, Helena B., Alkhouri, Naim, Allende, Daniela, Harisinghani, Mukesh, Noureddin, Mazen, Reau, Nancy S., French, Marika, Pantoja, Carlos, Mouchti, Sofia, Cryer, Donna R. H.

Volltext

Sticker shock and the price of new therapies for hepatitis C: Is it worth it? von Reau, Nancy S., Jensen, Donald M.

Volltext

Autoimmune hepatitis: Current and future therapies von Reau, Nancy S, Lammert, Craig S, Weinberg, Ethan M

Volltext

Generic medications for hepatitis C von Jensen, Donald M., Sebhatu, Phoebe, Reau, Nancy S.

Volltext

The benefit of paracentesis on hospitalized adults with cirrhosis and ascites von Gaetano, John N, Micic, Dejan, Aronsohn, Andrew, Reddy, Gautham, Te, Helen, Reau, Nancy S, Jensen, Donald

Volltext

Pangenotypic regimens and the next generation hepatitis C virus therapy von Reau, Nancy S.

Volltext

Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence von Sanyal, Arun J, Kowdley, Kris V, Reau, Nancy S, Pyrsopoulos, Nikolaos T, Allen, Christopher, Heimanson, Zeev, Bajaj, Jasmohan S

Volltext

Hepatitis C Virus: A Critical Appraisal of New Approaches to Therapy von Reau, Nancy S., Sherman, Kenneth, Terrault, Nora, Thomas, David, Nelson, David R., Jacobson, Ira, Gordon, Stuart C., Fried, Michael W., Jensen, Donald M., Sulkowski, Mark S., Everson, Greg

Volltext

Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus von Chung, Raymond T., Davis, Gary L., Jensen, Donald M., Masur, Henry, Saag, Michael S., Thomas, David L., Aronsohn, Andrew I., Charlton, Michael R., Feld, Jordan J., Fontana, Robert J., Ghany, Marc G., Godofsky, Eliot W., Graham, Camilla S., Kim, Arthur Y., Kiser, Jennifer J., Kottilil, Shyam, Marks, Kristen M., Martin, Paul, Mitruka, Kiren, Morgan, Timothy R., Naggie, Susanna, Raymond, Daniel, Reau, Nancy S., Schooley, Robert T., Sherman, Kenneth E., Sulkowski, Mark S., Vargas, Hugo E., Ward, John W., Wyles, David L.

Volltext

Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies? von Janardhan, Sujit V, Reau, Nancy S

Volltext

WED-498 Impact of direct-acting antiviral market access policy barriers and restrictions in patients with hepatitis C virus: A database analysis of US claims from states with and w... von Reau, Nancy S, Rajagopalan, Krithika, Makhija, Dilip, Turkistani, Fatema, Burk, Caroline, Rock, Marvin, Martin, Michelle

Volltext

Assessing treatment outcomes in an AIH/NAFLD overlap cohort von Belilos, Eleanor, Strzepka, Jessica, Jakate, Shiriam, Aloman, Costica, Reau, Nancy S

Volltext

Cost-effectiveness analysis of a new paradigm to simplify testing, monitoring and treatment of hepatitis C virus in the United States von Dieterich, Douglas T., Reau, Nancy S., Ahmed, Aijaz, Blissett, Rob, Igloi-Nagy, Adam, Yehoshua, Alon

Volltext

FRI-141 - Cost-effectiveness analysis of a new paradigm to simplify testing, monitoring and treatment of hepatitis C virus in the United States von Dieterich, Douglas T., Reau, Nancy S., Ahmed, Aijaz, Blissett, Rob, Igloi-Nagy, Adam, Yehoshua, Alon

Volltext

THU-460 - Assessing treatment outcomes in an AIH/NAFLD overlap cohort von Belilos, Eleanor, Strzepka, Jessica, Jakate, Shiriam, Aloman, Costica, Reau, Nancy S

Volltext

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection von Foster, Graham R, Afdhal, Nezam, Roberts, Stuart K, Bräu, Norbert, Gane, Edward J, Pianko, Stephen, Lawitz, Eric, Thompson, Alex, Shiffman, Mitchell L, Cooper, Curtis, Towner, William J, Conway, Brian, Ruane, Peter, Bourlière, Marc, Asselah, Tarik, Berg, Thomas, Zeuzem, Stefan, Rosenberg, William, Agarwal, Kosh, Stedman, Catherine A.M, Mo, Hongmei, Dvory-Sobol, Hadas, Han, Lingling, Wang, Jing, McNally, John, Osinusi, Anu, Brainard, Diana M, McHutchison, John G, Mazzotta, Francesco, Tran, Tram T, Gordon, Stuart C, Patel, Keyur, Reau, Nancy, Mangia, Alessandra, Sulkowski, Mark

Volltext